Article: FDA Okay Expected Soon for Melanoma Drug Ipilimumab

This is a good article on Ipi

http://www.internalmedicinenews.com/news/oncology-hematology/single-article/fda-okay-expected-soon-for-melanoma-drug-ipilimumab/b5ab2a8df2.html

An excerpt from the article:

This is a good article on Ipi

http://www.internalmedicinenews.com/news/oncology-hematology/single-article/fda-okay-expected-soon-for-melanoma-drug-ipilimumab/b5ab2a8df2.html

An excerpt from the article:

When chemotherapy works in advanced melanoma, it works quickly: A scan obtained after 6-8 weeks of therapy will show stability or shrinkage. That sort of response can also be seen with ipilimumab – but in addition, two novel patterns of response have been observed. One involves an initial increase in total tumor volume at the beginning of therapy, followed by delayed onset of stabilization or shrinkage.

Even more strikingly, some patients develop entirely new sites of metastatic disease when ipilimumab is started, with stabilization or shrinkage of both the new lesions and the baseline lesions coming several months later, according to Dr. Carvajal.